BHC - Bausch, Teva face lawsuit for delay in generic version of Xifaxan
2025-09-23 14:17:43 ET
More on Teva Pharmaceutical, Bausch Health Companies
- Olanzapine LAI (TEV-'749) Phase 3 SOLARIS Data Presentation
- Bausch Health: Repricing Continues As Deleveraging Gains Traction
- Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Insider trades: Salesforce, Broadcom among notable names this week
- Teva gets FDA fast track status for multiple system atrophy drug